Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 16: 44-53, 1970;
This Article
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campanini, R. Z.
Right arrow Articles by Natelson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campanini, R. Z.
Right arrow Articles by Natelson, S.

Clinical Chemistry, Vol 16, 44-53, Copyright © 1970 by the American Association for Clinical Chemistry

Evaluation of Serum Argininosuccinate Lyase (ASAL) Concentrations as an Index to Parenchymal Liver Disease

Rafael Z. Campanini 1, Rene A. Tapia 1, William Sarnat 1, and Samuel Natelson 1

1 Biochemistry Department, Michael Reese Hospital and Medical Center, Boston, Mass.

Serum concentrations of argininosuccinate lyase were determined in 122 patients with primary and secondary diseases of the liver. For comparison, patients with diseases involving other organs of the body were also studied. Extent of liver damage was evaluated by liver biopsy and in some cases, were assessed at autopsy. Daily assays, made during the course of the hospital stay, were correlated with blood concentrations of SGOT, SGPT, LDH, CPK, alkaline phosphatase, bilirubin, total and free cholesterol, and with the thymol turbidity and cephalin flocculation tests, and the albumin to globulin ratio. We tentatively conclude that, compared with these other commonly used tests of liver function, measurement of ASAL is a more specific and sensitive test for disease of the liver parenchyma. The procedure is simple and is readily made routine.

Submitted on May 6, 1969
Accepted on August 28, 1969




The following articles in journals at HighWire Press have cited this article:


Home page
 J. Pharmacol. Exp. Ther.Home page
T. C. Sarich, S. P. Adams, G. Petricca, and J. M. Wright
Inhibition of Isoniazid-Induced Hepatotoxicity in Rabbits by Pretreatment with an Amidase Inhibitor
J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 695 - 702.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by the American Association for Clinical Chemistry.